(Q43250802)
Statements
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer (English)
Trine Zeeberg Buch-Hansen
Lise Bentzen
Morten Hoeyer
Niels Viggo Jensen
Charlotte Saxe
31 October 2009